1MTB
Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy
Summary for 1MTB
Entry DOI | 10.2210/pdb1mtb/pdb |
Related | 1F7A 1HXB 1MT7 1MT8 1MT9 |
Related PRD ID | PRD_000454 |
Descriptor | PROTEASE RETROPEPSIN, (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1 -phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide (3 entities in total) |
Functional Keywords | hiv-1 protease, drug resistance, substrate recognition, inhibitor binding, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Human immunodeficiency virus 1 |
Cellular location | Gag-Pol polyprotein: Host cell membrane; Lipid-anchor. Matrix protein p17: Virion membrane; Lipid- anchor . Capsid protein p24: Virion . Nucleocapsid protein p7: Virion . Reverse transcriptase/ribonuclease H: Virion . Integrase: Virion : P03369 |
Total number of polymer chains | 2 |
Total formula weight | 22270.30 |
Authors | Prabu-Jeyabalan, M.,Nalivaika, E.A.,King, N.M.,Schiffer, C.A. (deposition date: 2002-09-20, release date: 2003-01-07, Last modification date: 2024-05-29) |
Primary citation | Prabu-Jeyabalan, M.,Nalivaika, E.A.,King, N.M.,Schiffer, C.A. Viability of drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy J.Virol., 77:1305-1315, 2003 Cited by PubMed: 12502847DOI: 10.1128/JVI.77.2.1306-1315.2003 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.5 Å) |
Structure validation
Download full validation report